series-c-plus
Stage
2014
Founded
5
Investors
About
DNA Script develops and manufactures an enzymatic DNA synthesis technology, enabling on-demand, in-house printing of nucleic acids for life sciences research and development. Their SYNTAX™ platform is an automated benchtop instrument for this purpose.
Explore DNA Script's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.